 Vancouver-based health science firm is pioneering a new generation of therapeutics for drug-resistant infection and cancer supportive care, with market approval of its Matrix3 anti-infective technology expected in Q1 2024. Andira Pharmaceuticals Based in Vancouver, Canada, Andira is a privately held health science firm that leverages natural cannabinoid compounds to accelerate the delivery of urgently ... The post US Capital Engaged by Canadian Health Science Pioneer Andira Pharmaceuticals as St... 